Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Guardant Health Net Income 2017-2020 | GH

Guardant Health annual/quarterly net income history and growth rate from 2017 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Guardant Health net income for the quarter ending March 31, 2020 was $-0.028B, a 6.44% increase year-over-year.
  • Guardant Health net income for the twelve months ending March 31, 2020 was $-0.077B, a 20.5% decline year-over-year.
  • Guardant Health annual net income for 2019 was $-0.076B, a 11.06% decline from 2018.
  • Guardant Health annual net income for 2018 was $-0.085B, a 4.42% decline from 2017.
  • Guardant Health annual net income for 2017 was $-0.089B, a 92.88% increase from 2016.
  
Guardant Health Annual Net Income
(Millions of US $)
2019 $-76
2018 $-85
2017 $-89
2016 $-46
Guardant Health Quarterly Net Income
(Millions of US $)
2020-03-31 $-28
2019-12-31 $-25
2019-09-30 $-13
2019-06-30 $-12
2019-03-31 $-26
2018-12-31 $-25
2018-09-30 $-24
2018-06-30 $-22
2018-03-31 $-14
2017-12-31
2017-09-30 $-33
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.919B $0.214B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $150.074B 16.52
Gilead Sciences (GILD) United States $95.408B 12.37
CSL (CSLLY) Australia $89.956B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.226B 51.03
Regeneron Pharmaceuticals (REGN) United States $67.020B 25.83
Illumina (ILMN) United States $54.177B 55.67
Biogen (BIIB) United States $43.207B 7.40
Seattle Genetics (SGEN) United States $28.998B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.819B 10.66
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
Moderna (MRNA) United States $22.864B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.757B 206.29
Incyte (INCY) United States $22.313B 0.00
Genmab (GMAB) Denmark $21.588B 17.78
Genmab (GNMSF) Denmark $20.261B 60.15
Alnylam Pharmaceuticals (ALNY) United States $17.162B 0.00
BeiGene (BGNE) Cayman Islands $14.631B 0.00
BioNTech SE (BNTX) Germany $14.512B 0.00
Galapagos (GLPG) Belgium $13.209B 38.86
Exact Sciences (EXAS) United States $13.106B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Sarepta Therapeutics (SRPT) United States $12.921B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.711B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.537B 25.93
Bio-Techne Corp (TECH) United States $10.168B 67.17
QIAGEN (QGEN) Netherlands $9.727B 28.28
Immunomedics (IMMU) United States $8.523B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.838B 0.00
Ascendis Pharma (ASND) Denmark $7.335B 0.00
Exelixis (EXEL) United States $7.206B 25.27
Repligen (RGEN) United States $6.496B 113.94
Adaptive Biotechnologies (ADPT) United States $6.063B 0.00
Acceleron Pharma (XLRN) United States $5.182B 0.00
Mirati Therapeutics (MRTX) United States $5.131B 0.00
Reata Pharmaceuticals (RETA) United States $5.116B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.864B 104.67
Vir Biotechnology (VIR) United States $4.669B 0.00
Zai Lab (ZLAB) China $4.631B 0.00
Novavax (NVAX) United States $4.619B 0.00
MyoKardia (MYOK) United States $4.381B 0.00
Emergent Biosolutions (EBS) United States $4.294B 28.15
Global Blood Therapeutics (GBT) United States $4.293B 0.00
Blueprint Medicines (BPMC) United States $4.282B 0.00
MorphoSys AG (MOR) Germany $4.260B 33.04
China Biologic Products (CBPO) China $4.014B 22.32
Amicus Therapeutics (FOLD) United States $4.007B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.742B 0.00
Halozyme Therapeutics (HALO) United States $3.721B 0.00
NeoGenomics (NEO) United States $3.503B 255.85
Bluebird Bio (BLUE) United States $3.396B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.249B 0.00
Arena Pharmaceuticals (ARNA) United States $3.145B 0.00
Alkermes (ALKS) Ireland $3.137B 61.75
Inovio Pharmaceuticals (INO) United States $3.119B 0.00
Insmed (INSM) United States $2.950B 0.00
Fate Therapeutics (FATE) United States $2.808B 0.00
Amarin (AMRN) Ireland $2.710B 0.00
Denali Therapeutics (DNLI) United States $2.666B 0.00
Viela Bio (VIE) United States $2.114B 0.00
UniQure (QURE) Netherlands $2.048B 0.00
PHARMA MAR SA (PHMMF) Spain $2.014B 0.00
Alector (ALEC) United States $1.973B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.968B 0.00
Principia Biopharma (PRNB) United States $1.929B 0.00
Twist Bioscience (TWST) United States $1.863B 0.00
Eidos Therapeutics (EIDX) United States $1.851B 0.00
Ligand Pharmaceuticals (LGND) United States $1.796B 69.94
Editas Medicine (EDIT) United States $1.704B 0.00
Adverum Biotechnologies (ADVM) United States $1.693B 0.00
I-Mab (IMAB) China $1.689B 0.00
Intra-Cellular Therapies (ITCI) United States $1.674B 0.00
Zymeworks (ZYME) Canada $1.656B 0.00
Epizyme (EPZM) United States $1.598B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.533B 0.00
Mersana Therapeutics (MRSN) United States $1.517B 0.00
Beam Therapeutics (BEAM) United States $1.468B 0.00
Sorrento Therapeutics (SRNE) United States $1.453B 0.00
REGENXBIO (RGNX) United States $1.443B 0.00
Revance Therapeutics (RVNC) United States $1.434B 0.00
Akcea Therapeutics (AKCA) United States $1.405B 0.00
Cytokineticsorporated (CYTK) United States $1.404B 0.00
Zealand Pharma (ZEAL) Denmark $1.381B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
Mesoblast (MESO) Australia $1.349B 0.00
Arvinas (ARVN) United States $1.337B 0.00
Sangamo Therapeutics (SGMO) United States $1.321B 0.00
NGM Biopharmaceuticals (NGM) United States $1.319B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.300B 0.00
Coherus BioSciences (CHRS) United States $1.294B 9.03
NantKwest (NK) United States $1.156B 0.00
Intellia Therapeutics (NTLA) United States $1.130B 0.00
Athenex (ATNX) United States $1.130B 0.00
Arcus Biosciences (RCUS) United States $1.077B 0.00
Compugen (CGEN) Israel $1.009B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.970B 0.00
Alcobra (ARCT) United States $0.960B 0.00
Retrophin (RTRX) United States $0.893B 0.00
Heska (HSKA) United States $0.872B 0.00
Myriad Genetics (MYGN) United States $0.839B 43.27
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.828B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.818B 0.00
Morphic Holding (MORF) United States $0.798B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Cellectis S.A (CLLS) France $0.767B 0.00
Dynavax Technologies (DVAX) United States $0.766B 0.00
Bellus Health (BLU) Canada $0.714B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.707B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.701B 0.00
Frequency Therapeutics (FREQ) United States $0.700B 0.00
Codexis (CDXS) United States $0.689B 0.00
VBI Vaccines (VBIV) United States $0.678B 0.00
Castle Biosciences (CSTL) United States $0.674B 0.00
Agenus (AGEN) United States $0.673B 0.00
Vericel (VCEL) United States $0.671B 123.92
Aquinox Pharmaceuticals (NLTX) United States $0.653B 0.00
Cue Biopharma (CUE) United States $0.652B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.651B 5.57
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
AnaptysBio (ANAB) United States $0.629B 0.00
MiMedx (MDXG) United States $0.597B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.576B 0.00
NextCure (NXTC) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.548B 17.61
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Cel-Sci (CVM) United States $0.540B 0.00
Athersys (ATHX) United States $0.534B 0.00
Prometic Life Sciences (LMNL) Canada $0.534B 0.00
UROGEN PHARMA (URGN) United States $0.533B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.525B 0.00
Syros Pharmaceuticals (SYRS) United States $0.522B 0.00
Scholar Rock Holding (SRRK) United States $0.521B 0.00
Clovis Oncology (CLVS) United States $0.514B 0.00
DBV Technologies S.A (DBVT) France $0.493B 0.00
Protagonist Therapeutics (PTGX) United States $0.480B 0.00
Merus (MRUS) Netherlands $0.465B 0.00
AC Immune SA (ACIU) Switzerland $0.463B 0.00
MeiraGTx Holdings (MGTX) United States $0.455B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.453B 0.00
Geron (GERN) United States $0.437B 0.00
Precision BioSciences (DTIL) United States $0.435B 0.00
BioDelivery Sciences (BDSI) United States $0.434B 22.79
Prothena (PRTA) Ireland $0.421B 0.00
Puma Biotechnology (PBYI) United States $0.419B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.416B 0.00
Avid Bioservices (CDMO) United States $0.403B 0.00
WAVE Life Sciences (WVE) Singapore $0.393B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Kamada (KMDA) Israel $0.392B 16.32
CytomX Therapeutics (CTMX) United States $0.391B 0.00
ANI Pharmaceuticals (ANIP) United States $0.386B 7.65
Affimed (AFMD) Germany $0.361B 0.00
MannKind (MNKD) United States $0.360B 0.00
Seres Therapeutics (MCRB) United States $0.348B 0.00
PDL BioPharma (PDLI) United States $0.347B 298.00
OSMOTICA PHARM (OSMT) United States $0.344B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Starpharma Holdings (SPHRY) Australia $0.303B 0.00
Celldex Therapeutics (CLDX) United States $0.302B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
Pfenex (PFNX) United States $0.283B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.283B 0.00
ChromaDex (CDXC) United States $0.278B 0.00
Verastem (VSTM) United States $0.273B 0.00
Spero Therapeutics (SPRO) United States $0.273B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.271B 0.00
IVERIC Bio (ISEE) United States $0.265B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.257B 0.00
Selecta Biosciences (SELB) United States $0.248B 0.00
IBio (IBIO) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
HOOKIPA Pharma (HOOK) United States $0.245B 0.00
Gritstone Oncology (GRTS) United States $0.244B 0.00
Dyadic (DYAI) United States $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Liquidia Technologies (LQDA) United States $0.235B 0.00
Five Prime Therapeutics (FPRX) United States $0.235B 0.00
Aptinyx (APTX) United States $0.226B 0.00
Fortress Biotech (FBIO) United States $0.224B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.220B 0.00
Pluristem Therapeutics (PSTI) Israel $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.215B 3.24
XOMA (XOMA) United States $0.212B 0.00
Strongbridge Biopharma (SBBP) United States $0.209B 0.00
Exicure (XCUR) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.209B 0.00
POXEL SA FRANCE (PXXLF) France $0.202B 0.00
Aduro Biotech (ADRO) United States $0.202B 0.00
ARAVIVE, INC (ARAV) United States $0.183B 0.00
Sutro Biopharma (STRO) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.178B 0.00
Aytu Bioscience (AYTU) United States $0.170B 0.00
Trevena (TRVN) United States $0.169B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Cyclerion Therapeutics (CYCN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.159B 0.00
VTv Therapeutics (VTVT) United States $0.155B 0.00
Cerecor (CERC) United States $0.153B 0.00
Theratechnologies (THTX) Canada $0.151B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
VolitionRX (VNRX) United States $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.148B 0.00
Celyad SA (CYAD) Belgium $0.147B 0.00
TELA Bio (TELA) United States $0.142B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
Orgenesis (ORGS) United States $0.127B 0.00
Arbutus Biopharma (ABUS) United States $0.126B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.122B 0.00
Eton Pharmaceuticals (ETON) United States $0.120B 0.00
Oncobiologics (OTLK) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
Palatin Technologies (PTN) United States $0.114B 2.93
Celsion (CLSN) United States $0.111B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
AquaBounty Technologies (AQB) United States $0.100B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cardiff Oncology (CRDF) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Clearside Biomedical (CLSD) United States $0.090B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Cocrystal Pharma (COCP) United States $0.077B 0.00
Organovo Holdings (ONVO) United States $0.073B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Signal Genetics (MGEN) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Vaccinex (VCNX) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Spherix (AIKI) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
MYOS RENS Technology (MYOS) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Novogen (KZIA) Australia $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
AEterna Zentaris (AEZS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00